Skip to content
10-Q

Quarterly Report

CardioGenics Holdings Inc.

0001493152-15-002591

← back to feed
Filed
Jun 22, 2015 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2015 · Jun 15, 2015 67.22M sh
Shares Diluted Q2 2015 · Apr 30, 2015 102.14M sh
Shares Diluted Q2 2015 · Apr 30, 2015 80.94M sh
Shares Diluted Q2 2015 · Apr 30, 2014 60.45M sh
Shares Diluted Q2 2015 · Apr 30, 2014 59.92M sh
Operating Cash Flow Q2 2015 · Apr 30, 2015 −$310.74K
Operating Cash Flow Q2 2015 · Apr 30, 2014 −$409.47K
Cash And Equivalents Q2 2015 · Apr 30, 2015 $37.85K
Cash And Equivalents Q2 2015 · Oct 31, 2014 $70.68K
Cash And Equivalents Q2 2015 · Apr 30, 2014 $1.98K
Cash And Equivalents Q2 2015 · Oct 31, 2013 $263.1K
Stockholders Equity Q2 2015 · Apr 30, 2015 −$1.32M
Stockholders Equity Q2 2015 · Oct 31, 2014 −$1.16M
Current Liabilities Q2 2015 · Apr 30, 2015 $1.55M
Current Liabilities Q2 2015 · Oct 31, 2014 $1.42M
Current Assets Q2 2015 · Apr 30, 2015 $41.17K
Current Assets Q2 2015 · Oct 31, 2014 $73.53K
Total Assets Q2 2015 · Apr 30, 2015 $229.24K
Total Assets Q2 2015 · Oct 31, 2014 $269.93K
Sga Expense Q2 2015 · Apr 30, 2015 $81.9K
Sga Expense Q2 2015 · Apr 30, 2015 $215.52K
Sga Expense Q2 2015 · Apr 30, 2014 $95.83K
Sga Expense Q2 2015 · Apr 30, 2014 $268.05K
Rd Expense Q2 2015 · Apr 30, 2015 $68.72K
Rd Expense Q2 2015 · Apr 30, 2015 $136.44K
Rd Expense Q2 2015 · Apr 30, 2014 $105.19K
Rd Expense Q2 2015 · Apr 30, 2014 $190.68K
Net Income Q2 2015 · Apr 30, 2015 $123.12K
Net Income Q2 2015 · Apr 30, 2015 −$937.71K
Net Income Q2 2015 · Apr 30, 2014 −$339.75K
Net Income Q2 2015 · Apr 30, 2014 −$748.14K
Operating Income Q2 2015 · Apr 30, 2015 −$154.81K
Operating Income Q2 2015 · Apr 30, 2015 −$360.51K
Operating Income Q2 2015 · Apr 30, 2014 −$205.39K
Operating Income Q2 2015 · Apr 30, 2014 −$467.56K